Biotech · Private company · San Francisco, CA, US
Gigamune, Inc.
Track this companyFree. Adds Gigamune, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- A Novel Lentivector for Enhanced In Vivo Delivery of T Cell Receptors for Cell Therapy for Stage IV MelanomaFiscal year 2026 · $1MNIH RePORTER 4R44CA310160-02 · fetched Nov 12, 2026
- A Novel Lentivector for Enhanced In Vivo Delivery of T Cell Receptors for Cell Therapy for Stage IV MelanomaFiscal year 2025 · $400KNIH RePORTER 1R44CA310160-01 · fetched Nov 12, 2026
- In vivo Sickle Cell Disease Gene Therapy Using a Novel Virus Like ParticleFiscal year 2024 · $300KNIH RePORTER 1R43HL174204-01A1 · fetched Nov 12, 2026